Position in INCY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$29,137,940
-$17,909,257 QoQ
Shares Held
257,039
-48.6% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#89
of 855 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,485,861,142 across 149 Biotechnology names. INCY ranks #27 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,137,940 | 257,039 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $47,047,197 | 499,864 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $55,522,270 | 562,137 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $49,750,816 | 586,615 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $38,350,718 | 563,153 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $43,013,205 | 710,375 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $44,214,054 | 640,134 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $40,132,350 | 607,146 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $52,020,870 | 858,147 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $53,288,027 | 935,370 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $55,947,835 | 891,031 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $49,954,295 | 864,710 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $21,951,029 | 352,627 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,883,138 | 39,894 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $317,825 | 3,957 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $281,953 | 4,231 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,636,544 | 21,542 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $17,260,426 | 217,331 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $15,903,870 | 216,674 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,881,514 | 85,512 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $282,340 | 3,356 | Shares | Defined | 2021-08-16 | |
| 2020-12-31 | $6,610 | 76 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $782,532 | 8,720 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,102,705 | 10,606 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $5,243,340 | 71,601 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||